BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 25751665)

  • 1. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
    Willemsen RT; van Severen E; Vandervoort PM; Grieten L; Buntinx F; Glatz JF; Dinant GJ
    Eur J Gen Pract; 2015; 21(3):156-63. PubMed ID: 25751665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE; Dekker MS; Hoes AW; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; Timmers L; de Kleijn DP; Glatz JF; Mosterd A
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of signs, symptoms and plasma heart-type fatty acid-binding protein (H-FABP) in evaluating patients presenting with symptoms possibly matching acute coronary syndrome: background and methods of a diagnostic study in primary care.
    Willemsen RT; Buntinx F; Winkens B; Glatz JF; Dinant GJ;
    BMC Fam Pract; 2014 Dec; 15():203. PubMed ID: 25738970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care.
    Bruins Slot MH; Rutten FH; van der Heijden GJ; Doevendans PA; Mast EG; Bredero AC; van der Spoel OP; Glatz JF; Hoes AW
    Int J Cardiol; 2013 Sep; 168(2):1485-9. PubMed ID: 23332896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome.
    Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Ducassé JL; Bottela JM; Lauque D
    Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performances of the heart fatty acid protein assay for the rapid diagnosis of acute myocardial infarction in ED patients.
    Dupuy AM; Cristol JP; Kuster N; Reynier R; Lefebvre S; Badiou S; Jreige R; Sebbane M
    Am J Emerg Med; 2015 Mar; 33(3):326-30. PubMed ID: 25547666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
    Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Fatty Acid Binding Protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction.
    Young JM; Pickering JW; George PM; Aldous SJ; Wallace J; Frampton CM; Troughton RW; Richards MA; Greenslade JH; Cullen L; Than MP
    BMC Emerg Med; 2016 Aug; 16(1):34. PubMed ID: 27577952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome.
    Valle HA; Riesgo LG; Bel MS; Gonzalo FE; Sanchez MS; Oliva LI
    Eur J Emerg Med; 2008 Jun; 15(3):140-4. PubMed ID: 18460953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome.
    Kellens S; Verbrugge FH; Vanmechelen M; Grieten L; Van Lierde J; Dens J; Vrolix M; Vandervoort P
    Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):177-84. PubMed ID: 25666938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
    Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of heart-type fatty acid-binding protein (H-FABP) for emergency department patients with suspected acute coronary syndrome.
    Banu KY; Niyazi OD; Erdem C; Dpekçi Afşin DH; Ozlem U; Yasemin C; Afsin I
    Afr Health Sci; 2014 Sep; 14(3):757-62. PubMed ID: 25352899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
    Inoue K; Suwa S; Ohta H; Itoh S; Maruyama S; Masuda N; Sugita M; Daida H
    Circ J; 2011; 75(12):2813-20. PubMed ID: 21937835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.
    Bhardwaj A; Truong QA; Peacock WF; Yeo KT; Storrow A; Thomas S; Curtis KM; Foote RS; Lee HK; Miller KF; Januzzi JL
    Am Heart J; 2011 Aug; 162(2):276-282.e1. PubMed ID: 21835288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
    Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
    Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome.
    Mueller M; Biener M; Vafaie M; Blankenberg S; White HD; Katus HA; Giannitsis E
    Int J Cardiol; 2014 Jul; 174(3):524-9. PubMed ID: 24814895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Exclusion of Major Adverse Cardiac Events in Emergency Department Chest Pain Patients: A Prospective Observational Study.
    Leung YK; Cheng NM; Chan CP; Lee A; Wong JK; Yan BP; Ahuja AT; Graham CA; Rainer TH
    J Emerg Med; 2017 Sep; 53(3):287-294. PubMed ID: 28992867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
    Charpentier S; Ducassé JL; Cournot M; Maupas-Schwalm F; Elbaz M; Baixas C; Juchet H; Lang T; Lauque D
    Acad Emerg Med; 2010 Jan; 17(1):27-35. PubMed ID: 20078436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.